区分遗忘型轻度认知障碍与HIV相关神经认知障碍
结果显示,高遗忘型轻度认知障碍(aMCI)风险在HIV相关神经认知障碍(HAND)组占69.0%,无HAND组占37.5%;高aMCI风险组β-淀粉样蛋白病理可能性是低风险组的4.75倍,磷酸化Tau病理无差异。结论提示,包含再认障碍的aMCI标准可能有助于在HIV感染者中识别类阿尔茨海默病的认知/生物标志物特征。
要点
- 在HIV感染者中,高aMCI风险在HAND组占69.0%,无HAND组占37.5%。
- 高aMCI风险组β-淀粉样蛋白病理可能性是低风险组的4.75倍。
- 磷酸化Tau病理及HAND状态与两种神经病理特征均无差异。
核心结论
- 包含再认障碍的遗忘型轻度认知障碍标准可能有助于在HIV感染者中检测类阿尔茨海默病的认知/生物标志物特征。
主要发现
- 高aMCI风险在HAND组占69.0%,在无HAND组占37.5%。
- 高aMCI风险组β-淀粉样蛋白病理可能性是低aMCI风险组的4.75倍。
- 磷酸化Tau病理在高、低aMCI风险组间无差异,两种神经病理特征在HAND状态间也无差异。
关键数值与推荐
- 高aMCI风险定义为:在词语和非词语记忆测验的4项延迟回忆或再认结果中,至少2项低于常模均值1.0个标准差以下,且至少1项为再认障碍。
临床怎么用
- 对HIV感染者进行认知评估时,采用包含再认障碍的aMCI标准可能帮助识别具有类阿尔茨海默病病理特征的高风险个体。
局限性
- 仅检测额叶脑组织的β-淀粉样蛋白和磷酸化Tau病理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Memory impairment occurs in human immunodeficiency virus (HIV)-associated neurocognitive disorders (HAND) and amnestic mild cognitive impairment (aMCI), the precursor to Alzheimer disease (AD). Methods are needed to distinguish aMCI-associated from HAND-associated impairment in people with HIV (PWH). We developed a neuropsychological method of identifying aMCI in PWH and tested this by relating AD neuropathology (β-amyloid, phospho-Tau) to aMCI versus HAND classification. METHODS: Seventy-four HIV-positive cases (aged 50-68 years) from the National NeuroAIDS Tissue Consortium had neurocognitive data within 1 year of death and data on β-amyloid and phospho-Tau pathology in frontal brain tissue. High aMCI risk was defined as impairment (<1.0 SD below normative mean) on 2 of 4 delayed recall or recognition outcomes from a verbal and nonverbal memory test (at least 1 recognition impairment required). Differences in β-amyloid and phospho-Tau by aMCI and HAND classification were examined. RESULTS: High aMCI risk was more common in HAND (69.0%) versus no HAND (37.5%) group. β-amyloid pathology was 4.75 times more likely in high versus low aMCI risk group. Phospho-Tau pathology did not differ between aMCI groups. Neither neuropathological feature differed by HAND status. CONCLUSIONS: Amnestic mild cognitive impairment criteria that include recognition impairment may help to detect AD-like cognitive/biomarker profiles among PWH.
引用
- Sundermann EE, Bondi MW, Campbell LM, et al. Distinguishing Amnestic Mild Cognitive Impairment From HIV-Associated Neurocognitive Disorders. J Infect Dis. 2021. PMID: 33319235. doi:10.1093/infdis/jiaa760
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。